dublin < due < dummy

Facettes : Author.f AffPays.f AffOrg.f AffRegion.f AffVille.f

List of bibliographic references

Number of relevant bibliographic references: 48.
[0-20] [0 - 20][0 - 48][20-40]

Ident.	Authors (with country if any)	Title
000011 (2012)	Emilio Besada [Norvège] ; Johannes C. Nossent [Norvège]	Ultrasonographic resolution of the vessel wall oedema with modest clinical improvement in a large-vessel vasculitis patient treated with tocilizumab
000021 (2010)	Nicolas Frey [Suisse] ; Susan Grange [Suisse] ; Thasia Woodworth [Royaume-Uni]	Population Pharmacokinetic Analysis of Tocilizumab in Patients With Rheumatoid Arthritis
000032 (2010)	Daichi Inoue [Japon] ; Hiroshi Arima [Japon] ; Chiharu Kawanami [Japon] ; Yoko Takiuchi [Japon] ; Seiji Nagano [Japon] ; Takaharu Kimura [Japon] ; Sonoko Shimoji [Japon] ; Minako Mori [Japon] ; Sumie Tabata [Japon] ; Soshi Yanagita [Japon] ; Akiko Matsushita [Japon] ; Kenichi Nagai [Japon] ; Yukihiro Imai [Japon] ; Takayuki Takahashi [Japon]	Excellent therapeutic effect of tocilizumab on intestinal amyloid a deposition secondary to active rheumatoid arthritis
000051 (2008)	Atsushi Taga [Japon] ; Soichiro Kita ; Kaori Nishiura [Japon] ; Tomonori Hayashi [Japon] ; Mitsuhiro Kinoshita ; Atsushi Sato [Japon] ; Kentaro Suzuki [Japon] ; Shuji Kodama [Japon] ; Kazuaki Kakehi	Analysis of an antibody pharmaceutical, tocilizumab, by capillary electrophoresis using a carboxylated capillary
000083 (2012)	Yasuhiko Hirabayashi [Japon] ; Tomonori Ishii [Japon]	The DAS28-ESR cutoff value necessary to achieve remission under the new Boolean-based remission criteria in patients receiving tocilizumab
000091 (2012)	Sooha Kim [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]	Interleukin-6 and cytochrome-P450, reason for concern?
000096 (2009)	Hiroe Sato [Japon] ; Takehito Sakai [Japon] ; Toshiaki Sugaya [Japon] ; Yasuhiro Otaki [Japon] ; Kana Aoki [Japon] ; Katsushi Ishii [Japon] ; Hidehiro Horizono [Japon] ; Hiroshi Otani [Japon] ; Asami Abe [Japon] ; Noboru Yamada [Japon] ; Hajime Ishikawa [Japon] ; Kiyoshi Nakazono [Japon] ; Akira Murasawa [Japon] ; Fumitake Gejyo [Japon]	Tocilizumab dramatically ameliorated life-threatening diarrhea due to secondary amyloidosis associated with rheumatoid arthritis
000175 (2012)	P. Lehmann [Allemagne] ; E. Huber [Allemagne] ; T. Dörner [Allemagne] ; M. Fleck [Allemagne]	Makrophagenaktivierungssyndrom
000178 (2010)	G. Dückers [Allemagne] ; T. Niehues [Allemagne]	Die Bedeutung von Biologika bei der Therapie der SoJIA (Morbus Still)
000296 (2012)	Adel Alawadhi [Koweït] ; Khaldoon Alawneh [Jordanie] ; Zeyad Ahmed Alzahrani [Arabie saoudite]	The effect of neutralizing antibodies on the sustainable efficacy of biologic therapies: what’s in it for African and Middle Eastern rheumatologists
000507 (2013)	Todd A. Morrison [États-Unis] ; Mark Figgie [États-Unis] ; Andy O. Miller [États-Unis] ; Susan M. Goodman [États-Unis]	Periprosthetic Joint Infection in Patients with Inflammatory Joint Disease: a Review of Risk Factors and Current Approaches to Diagnosis and Management
000513 (2010)	M. Feuchtenberger [Allemagne] ; R. E. Voll [Allemagne] ; C. Kneitz [Allemagne]	Impfungen in der Rheumatologie
000530 (2011)	Dimitrios Christidis [Royaume-Uni] ; Shaifali Jain [Royaume-Uni] ; Bhaskar Das Gupta [Royaume-Uni]	Successful use of tocilizumab in polymyalgic onset biopsy positive GCA with large vessel involvement
000585 (2013)	A. Alexeeva [Russie] ; Y. Mouraviev [Russie] ; E. Nasonov [Russie]	AB0341 Experience of tocilizumab usage in chronic renal insufficiency stipulated by aa-amyloidosis due to rheumatoid arthritis complication
000803 (2012)	Sharon Cohen [Israël] ; Ilan Bruchim [Israël] ; Dror Graiver [Israël] ; Zoharia Evron [Israël] ; Varda Oron-Karni [Israël] ; Metsada Pasmanik-Chor [Israël] ; Ram Eitan [Israël] ; Joelle Bernheim [Israël] ; Hanoch Levavi [Israël] ; Ami Fishman [Israël] ; Eliezer Flescher [Israël]	Platinum-resistance in ovarian cancer cells is mediated by IL-6 secretion via the increased expression of its target cIAP-2
000821 (2013)	R. Kessel [États-Unis] ; C. Hu [États-Unis] ; L. Shore-Lesserson [États-Unis] ; J. Rand [États-Unis] ; D. Manwani [États-Unis]	A child with acquired factor XIII deficiency: case report and literature review
000853 (2013)	Andra Balanescu [Roumanie] ; Piotr Wiland [Pologne]	Maximizing early treatment with biologics in patients with rheumatoid arthritis: the ultimate breakthrough in joints preservation
000A38 (2010)	T. Schmeiser [Allemagne] ; U. Müller- Ladner [Allemagne]	Therapie mit Certolizumab pegol bei Patienten mit destruierender Arthritis
000A42 (2012)	Meryem Can [Turquie] ; Fatma Alibaz-Öner [Turquie] ; Sibel Y Lmaz-Öner [Turquie] ; Pamir Atagündüz [Turquie] ; Nevsun Nanç [Turquie] ; Haner Direskeneli [Turquie]	Accelerated infusion rates of rituximab are well tolerated and safe in rheumatology practice: a single-centre experience
000A51 (2013)	Christian Gissel [Allemagne] ; Holger Repp [Allemagne]	Cost per responder of TNF-α therapies in Germany
000A56 (2009)	T. Brünnler [Allemagne] ; F. Bataille [Allemagne] ; F. Hofst Dter [Allemagne] ; G. Birkenfeld [Allemagne] ; J. Schölmerich [Allemagne]	41-jähriger Patient mit unklarer Diarrhö

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "due" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "due" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    due
}}

---

This area was generated with Dilib version V0.6.34. Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021